Suggestions
Camilla Languille
Head of Life Sciences at Mubadala
Professional Background
Camilla Languille is a distinguished investment professional with almost two decades of diverse experience spanning business development, asset management, and mergers and acquisitions (M&A). Her impressive track record across multiple regions, including Europe, North America, and the Middle East and North Africa (MENA), showcases her expertise in navigating complex corporate finance and principal investment landscapes. Currently, Camilla serves as the Director of Mubadala Investment Company, a prestigious sovereign wealth fund based in Abu Dhabi, boasting assets under management of approximately $250 billion. In her current role, she leads the Life Sciences investments unit, concentrating on the business development and management of its extensive life sciences portfolio. This dynamic portfolio encompasses a wide array of investments in sectors such as pharmaceuticals, medical technology, life science tools and diagnostics, healthcare information technology, healthcare services, and animal health. Under her leadership, the team at Mubadala successfully manages investments across various asset classes, which include private equity, public equities, and funds.
In her capacity at Mubadala Investment Company, Camilla has effectively managed significant investments, including a strategic interest in Advanced Micro Devices (AMD), where she was responsible for business development within the technology sector. Additionally, she played a pivotal role in overseeing investments in power generation assets located in Oman and Algeria, and was instrumental in the management of a gold mining asset in Colombia as well as a district cooling asset known as Tabreed. Camilla's robust experience also covers the development of conventional power projects aligned with Mubadala's broader strategy.
Education and Achievements
Camilla Languille's educational background is as impressive as her career trajectory. She graduated summa cum laude from Columbia University in 2004, earning a Bachelor of Economics and Political Science. Her foundation in these subjects has undoubtedly equipped her with the analytical skills and strategic mindset crucial for success in the multifaceted world of investment.
Prior to her tenure at Mubadala, Camilla honed her skills in mergers and acquisitions during her time at Daiwa Capital and Société Générale in Paris, France. Here, she completed numerous cross-border transactions across various sectors, further solidifying her expertise in M&A processes and corporate finance.
Her noteworthy career also includes serving as an Investment Manager within the Virgin Group’s headquarters in London, where she effectively managed the Special Situations portfolio. Camilla's leadership played a crucial part in the restructuring of Virgin Drinks and the successful launch of Virgin Healthcare. Additionally, her role in the corporate finance team was paramount as it supported the other portfolios during various M&A transactions, equity and debt financings, and restructuring efforts.
Achievements
From the outset of her career, Camilla Languille distinguished herself with a strong focus on the healthcare sector while working in Healthcare M&A for JPMorgan in New York and London. This initial engagement provided her with a robust foundation in pharmaceutical and biotechnology investments, setting the stage for her future successes.
Her multilingual capabilities, being fluent in both English and French, complement her international upbringing and extensive experience living in 14 countries across four continents. As a Canadian national, Camilla has not only navigated global markets with ease but also cultivated a deep understanding of diverse business cultures, making her a valuable asset in the investment realm.
Throughout her career, Camilla has exemplified leadership, strategic vision, and a commitment to fostering growth in the organizations she has been part of. Her role at Mubadala underscores her capabilities in steering investments that align health sciences with innovation, all while prioritizing sustainable and impactful returns.
tags:[
Investment professional
Business development
Asset management
M&A
Healthcare
Technology
Industrials
Mubadala Investment Company
Life Sciences investments
Corporate finance
Advanced Micro Devices
JPMorgan
Daiwa Capital
Société Générale
Virgin Group
Columbia University
International experience
Cross-border transactions
Private equity
Public equities
Financial services
Fluent in English
Fluent in French
